Navigating The Treatment of Schizophrenia Using LAIs In The Time of COVID-19
The rapid onset of COVID-19 in the United States, combined with the dismantling of the spring 2020 medical conference infrastructure and widespread travel bans and social distancing has created a synchronous need in all clinical arenas to manage patients with pre-existing conditions, such as schi
Category
  • Psychiatry
Format
  • Webinar recorded
Credits
  • AANP Contact Hours
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Best Practices for Using Long-acting Injectable Antipsychotics during COVID-19
​​​​​​Join Drs Les Citrome, Steve Stoner, and Board Certified Family Psychiatric Nurse Practitioner Tory Woodward for this on-demand online activity, as they discuss considerations for implementing LAI clinics and best practices for communicating with patients, caregivers, and clinicians regardin
Category
  • Psychiatry
Format
  • Self-study / Enduring
  • Webinar recorded
Credits
  • AANP Contact Hours
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Optimizing the Role of the Pharmacist in LAI Administration During COVID-19
In recent years, overwhelming evidence suggests that LAIs may improve adherence, reduce relapse and hospitalizations, lessen the risk of treatment failure, and decrease mortality.
Category
  • Psychiatry
Format
  • Self-study / Enduring
  • Webinar recorded
Credits
  • AANP Contact Hours
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
2020 and Beyond: How Immunotherapy is Changing the Game in Bladder Cancer Management
It is estimated that there are >81,000 new cases of metastatic urothelial bladder cancer (mUBC) in the U.S each year, resulting in more than 17,000 bladder cancer specific deaths.
Category
  • Oncology
Format
  • Webinar recorded
Credits
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Focusing on the Role of the Advanced Bladder Cancer Care Team: Case Studies on Managing irAEs
Join Drs. Neal Shore, Gautam Jayram, and Nurse Tanya O’Neal as they discuss clinical considerations for managing immune-related adverse events that may occur at any time during therapy and, as of yet, there is no reliable means to predict who will develop them.
Category
  • Oncology
Format
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
IO Therapies in the Advanced Bladder Cancer Clinic: Aligning Your Team for Success
As the treatment paradigm for bladder cancer continuously evolves, all members of the oncology healthcare team must be equipped to evolve with it to ensure optimal patient care. With this evolution comes many questions for the bladder cancer treatment team. Join Drs.
Category
  • Oncology
Format
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Future Directions in Bladder Cancer Treatment: The Experts Weigh In
Immunotherapies are revolutionizing many cancer treatment regimens and show promise in locally advanced or metastatic bladder cancer. Immune checkpoint inhibitors are attempting to fill an unmet need in relapsed disease and biomarkers may assist in identifying patients most likely to respond.
Category
  • Oncology
Format
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Betting on BTK Inhibitors in CLL: Where are We Now and Where are We Going?
This initiative is targeted to addressing the professional practice of pharmacists in hospitals, health systems, ambulatory care clinics, and other settings.
Category
  • Oncology
Format
  • Webinar live
Credits
  • ACPE Pharmacy
  • Participation
Event date February 2, 2021
Stepping Beyond the Status Quo in Heart Failure: The Revolutionary Role of SGLT2 Inhibition
This Grand Rounds initiative is targeted to cardiologists, endocrinologists, primary care physicians, pharmacists, nurses, nurse practitioners, and physician assistants.
Category
  • Cardiology
Format
  • Webinar live
Credits
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
Event date February 5, 2021
Traversing New Terrains In CLL: The Emerging Role Of BTK Inhibitors In The Treatment Landscape
CANCELLED 
Category
  • Oncology
Format
  • Webinar live
Credits
  • ANCC
  • Participation

Pages